期刊文献+

LC-MS在体内药物分析方法学研究中常见的问题及其对策 被引量:12

LC-MS in biomedical analysis:Common issues and counterplan
原文传递
导出
摘要 液相色谱-质谱联用技术(liquid chromatography-mass spectrometry,LC-MS)已成为体内药物分析及其相关研究领域中不可或缺的工具.虽然该技术具有高选择性、高灵敏度以及高通量等特点,但在体内药物分析方法学研究中,仍然会面临诸如待测物需衍生化、复方制剂体内多组分同时测定时高浓度组分的质谱响应饱和、方法专属性误判、基质效应、残留效应等一系列挑战和问题,本文综述了这些常见问题的相应对策. Liquid chromatography-mass spectrometry(LC-MS) is currently the method of choice for the biomedical analysis.The advantages of this technique include high specificity,sensitivity and throughput.However,in practical terms,we still face many challenges and/or problems,such as derivatization,MS response saturation to high content components in simultaneous determination of the multi-component,false-positive results of specificity,matrix effect and carry-over effect.In this review,these issues and their counterplan in bioanalytical LC-MS method development and validation are discussed and illustrated with some examples.
出处 《中国科学:化学》 CAS CSCD 北大核心 2010年第6期611-620,共10页 SCIENTIA SINICA Chimica
关键词 液相色谱-质谱联用 体内药物分析 衍生化 专属性 基质效应 残留效应 liquid chromatography-mass spectrometry biomedical analysis derivatization specificity matrix effect carry-over effect
  • 相关文献

参考文献4

二级参考文献36

  • 1刘鲁,王菊,仲英.第三代长效血管紧张素转换酶抑制剂——佐芬普利钙[J].齐鲁药事,2005,24(11):701-702. 被引量:8
  • 2徐红蓉,汪红,陈伟力,李雪宁,储楠楠,周密.氨溴索分散片在健康志愿者的药代动力学和生物等效性[J].中国临床药理学杂志,2006,22(3):180-183. 被引量:10
  • 3Davis KL, Nappi JM. The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist [J]. Clin Ther, 2003, 25: 2647-2668.
  • 4Zhang JY, Fast DM, Breau AE Development and validation of a liquid chromatography-tandem mass spectrometric assay for eplerenone and its hydrolyzed metabolite in human plasma [J]. J Chromatogr B, 2003, 787: 333-344.
  • 5Cook CS, Zhang LM. lnterconversion pharmacokinetics of eplerenone, a selective aldosterone blocker, and its lactonering open form [J]. J Pharm Sci, 2002, 91:1383-1389.
  • 6Cook CS, Berry LM, Bible RH. Pharmacokinetics and metabolism of [14C]eplerenone after oral administration to humans [J]. Drug Metab Dispos, 2003, 31: 1448-1455.
  • 7Ravis WR, Reid S, Sica DA, et al. Pharmacokinetics of eplerenone after single and multiple dosing in subjects with and without renal impairment [J]. J Clin Pharmacol, 2005, 45 810-821.
  • 8Meineke I, Gleiter CH. Assessment of drug accumulation in the evaluation of pharmacokinetic data [J]. J Clin Pharmacol, 1998, 38: 680-684.
  • 9Ding L, Li L, Ma PC. Determination of azelnidipine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry [J]. J Pharm Biomed Anal, 2007, 43: 575-579.
  • 10Zhao LH, Ding L, Wei X. Determination of moxonidine in human plasma by liquid chromatography-electrospray ionisation-mass spectrometry [J]. J Pharm Biomed Anal, 2006, 40: 95-99.

共引文献20

同被引文献168

引证文献12

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部